The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.
about
Dual-Component Gelatinous Peptide/Reactive Oligomer Formulations as Conduit Material and Luminal Filler for Peripheral Nerve Regeneration.HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.Influence of N-methyl pyrrolidone on the activity of the pulp-dentine complex and bone integrity during osteoporosis.Letter to the Editor, "BET inhibitor JQ1 blocks inflammation and bone destruction".N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.N-Methyl Pyrrolidone (NMP) Alleviates Lipopolysaccharide (LPS)-Induced Inflammatory Injury in Articular ChondrocytesReproducibility: Check your chemistry
P2860
Q33755490-43F13482-E275-47EB-9878-292F9C103469Q39307665-FC818309-3F00-4F28-AADA-FC08255E0E60Q48230133-98AC1379-9C34-417D-BA9B-32F719BD93E2Q54722445-72CB81DE-FEB6-41D1-9530-96A883EF21F9Q55057199-F2560D6F-186D-421D-873A-14B1188E8047Q58737317-B93E7294-3C3A-41DC-982B-777E440F6FECQ59068868-7E372A71-C2A2-4F86-AECC-1261CE88A654
P2860
The drug vehicle and solvent N-methylpyrrolidone is an immunomodulator and antimyeloma compound.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@en
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@nl
type
label
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@en
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@nl
prefLabel
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@en
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@nl
P2093
P50
P1433
P1476
The drug vehicle and solvent N ...... ator and antimyeloma compound.
@en
P2093
Andrea Reitsma
Andy K Hsu
Benjamin P Martin
Daniel M Andrews
David Faulkner
David S Ritchie
Geoffrey M Matthews
Karen Doggett
Maria A Doyle
Marta Chesi
P304
P356
10.1016/J.CELREP.2014.04.008
P577
2014-05-09T00:00:00Z